alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals

Fifth Circuit 

## FILED February 23, 2006 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 05-40830 Conference Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus LEODEGARIO GUZMAN, Defendant-Appellant.

-------------------- Appeal from the United States District Court for the Southern District of Texas USDC No. 7:04-CR-154-1

-------------------- Before GARZA, DENNIS, and PRADO, Circuit Judges.
PER CURIAM: * Leodegario Guzman appeals his conviction and sentence following his guilty plea to importation of more than one kilogram of heroin into the United States. Guzman correctly notes that his argument, made for the first time on appeal, that the district court lacked jurisdiction to convict and sentence him because 21 U.S.C. § 841 is unconstitutional under Apprendi v. New Jersey , 530 U.S. 466 (2000), is foreclosed by United States v. Slaughter , 238 F.3d 580, 582 (5th Cir. 2000).No. 05-40830 -2- Guzman also argues for the first time on appeal that the district court abused its discretion when it imposed a condition of supervised release that requires him to cooperate in the collection of his DNA. Guzman’s claim is not ripe for review.
See United States v. Riascos-Cuenu , 428 F.3d 1100, 1101-02 (5th Cir. 2005), petition for cert. filed (Jan. 9, 2006) (No. 05- 8662). Therefore, this court lacks jurisdiction to review this claim.
AFFIRMED IN PART; DISMISSED IN PART.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Institutional Network Applications for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-TL1).                    

*Date:*                         March 26-27, 2024.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate cooperative agreement applications.                    

*Place:*                         National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Jason D. Hoffert, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Activities, NIDDK, National Institutes of Health, Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20892, 301-496-9010,                         *hoffertj@niddk.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: November 29, 2023.

Miguelina Perez, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-26630 Filed 12-4-23; 8:45 am]

BILLING CODE 4140-01-P
# C_2018392EN.01000901.xml

| 29.10.2018 | EN | Official Journal of the European Union | C 392/9 |
| --- | --- | --- | --- |

29.10.2018

EN

Official Journal of the European Union

C 392/9

---

Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 10 August 2018 — Dr. Willmar Schwabe GmbH & Co.KG v Queisser Pharma GmbH & Co. KG

(Case C-524/18)

(2018/C 392/13)

Language of the case: German

Referring court

Bundesgerichtshof

Parties to the main proceedings

Applicant: Dr. Willmar Schwabe GmbH & Co.KG

Defendant: Queisser Pharma GmbH & Co. KG

Questions referred

| 1. | Is a reference to general, non-specific health-related benefits ‘accompanied’ within the meaning of Article 10(3) of Regulation (EC) No 1924/2006 (1) by specific health claims in accordance with one of the lists provided for in Article 13 or 14 of that regulation even if that reference is situated on the front and the authorised claims are situated on the back of an outer packaging and, in the perception of the public, although the claims are clearly related to the reference in terms of content, the reference does not contain a clear indication, marked with an asterisk for example, to the claims on the back? |
| --- | --- |

1.

Is a reference to general, non-specific health-related benefits ‘accompanied’ within the meaning of Article 10(3) of Regulation (EC) No 1924/2006 (1) by specific health claims in accordance with one of the lists provided for in Article 13 or 14 of that regulation even if that reference is situated on the front and the authorised claims are situated on the back of an outer packaging and, in the perception of the public, although the claims are clearly related to the reference in terms of content, the reference does not contain a clear indication, marked with an asterisk for example, to the claims on the back?

| 2. | Does evidence within the meaning of Article 5(1)(a) and Article 6(1) of Regulation (EC) No 1924/2006 also need to be provided in the case of reference being made to general, non-specific benefits within the meaning of Article 10(3) of that regulation? |
| --- | --- |

2.

Does evidence within the meaning of Article 5(1)(a) and Article 6(1) of Regulation (EC) No 1924/2006 also need to be provided in the case of reference being made to general, non-specific benefits within the meaning of Article 10(3) of that regulation?

---

(1)  Commission Regulation (EU) No 1047/2012 of 8 November 2012 amending Regulation (EC) No 1924/2006 with regard to the list of nutrition claims Text with EEA relevance, OJ 2012 L 310, p. 36.

---
FIFTH DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________ 

Case No. 5D23-1121 

LT Case No. 2009-CF-002359

_____________________________ 

CALVA HASKELL, 

Appellant, 

v.

STATE OF FLORIDA, 

Appellee. 

_____________________________ 

3.800 appeal from the Circuit Court for Lake County. 

G. Richard Singeltary, Judge.

Calva Haskell, Bushnell, pro se. 

Ashley Moody, Attorney General, Tallahassee, and Kristen L. 

Davenport, Assistant Attorney General, Daytona Beach, for 

Appellee. 

September 5, 2023

PER CURIAM.

AFFIRMED. 

EDWARDS, C.J., MAKAR, and HARRIS, JJ., concur. 
2

_____________________________

Not final until disposition of any timely and 

authorized motion under Fla. R. App. P. 9.330 or 

9.331.

_____________________________
May 15, 2008

27697, 27824

#### Ramsey v. State

Affirmed; Vacated and Remanded
IN THE DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FIFTH DISTRICT

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

SCOTT ALLISON DAMASIEWICZ,

Petitioner,

v. Case No. 5D16-2848

STATE OF FLORIDA,

Respondent.

________________________________/

Opinion filed September 9, 2016

Petition for Belated Appeal

A Case of Original Jurisdiction. 

Jonathan Meltz, of The Meltz Law Firm, 

Miami, for Petitioner.

No Appearance for Respondent.

PER CURIAM. 

The petition for belated appeal is granted. A copy of this opinion shall be filed with 

the trial court and be treated as the notice of appeal from the April 18, 2016, judgment 

and sentence in Case No. 2012-CF-001406-E-03, in the Circuit Court in and for Lake

County, Florida. See Fla. R. App. P. 9.141(c)(6)(D). 

PETITION GRANTED.

EDWARDS, TORPY and BERGER, JJ., concur.
#### Benitez v. Travis

16620

10/03/96

Affirmed
Exhibit 32

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND 

PRINCIPAL FINANCIAL OFFICER 

PURSUANT TO 18 U.S.C. SECTION 1350 

AS ADDED BY SECTION 906 OF THE 

SARBANES-OXLEY ACT OF 2002

 

 

In connection with the quarterly report of Mid Penn Bancorp, Inc. (the “Corporation”) on Form 10-Q for the period ending September 30, 2015, as filed with the Securities and Exchange Commission on November 13, 2015 (the “10-Q”) and Amendment No. 1 to the quarterly report on Form 10-Q/A as filed with the Securities and Exchange Commission on the date hereof (the “10-Q/A” and, together with the 10-Q, the “Report”), I, Rory G. Ritrievi, President and CEO, and I, Edward P. Williams, Interim Principal Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as added pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

|  | 1. |  | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934. |
|--|----|--|-------------------------------------------------------------------------------------------------------------------|

 

|  | 2. |  | To my knowledge, the information contained in the Report fairly presents, in all material respects the financial condition and results of operations of Mid Penn Bancorp, Inc. as of the dates and for the periods expressed in the Report.  |
|--|----|--|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

 

 

 

|   |                 |
|--------|----------------------|
|   |                 |
|   |                 |
|   |                 |
| By:    | /s/ Rory G. Ritrievi |
|   | President and CEO    |
| Date:  | November 13, 2015    |

 

 

 

|   |                                |
|--------|-------------------------------------|
|   |                                |
|   |                                |
|   |                                |
|   |                                |
| By:    | /s/ Edward P. Williams              |
|   | Interim Principal Financial Officer |
| Date:  | November 13, 2015                   |

 

 

----
February 11, 1999

21798

#### Cunningham v. Board of Chiropractic Examiners, Dept. of Commerce and Consumer Affairs

Affirmed
# C_2016203EN.01002601.xml

| 7.6.2016 | EN | Official Journal of the European Union | C 203/26 |
| --- | --- | --- | --- |

7.6.2016

EN

Official Journal of the European Union

C 203/26

---

Article 58

Where a producer carries out several stages of production from extraction of the ore up to and including production of the metal, he may offer the product to the Agency at whichever stage of production he chooses.

The same shall apply to two or more connected undertakings, where the connection has been duly communicated to the Commission and discussed with it in accordance with the procedures laid down in Articles 43 and 44.

---
EXHIBIT 31.b

I, Marc Teal, certify that:

1.	I have reviewed this quarterly report on Form 10-K of Boston Capital Tax Credit Fund III L.P (the "Fund");



1. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
2. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this quarterly report;
3. The Fund's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the Company and we have:



1. designed such disclosure controls and procedures to ensure that material information relating to the Fund, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
2. evaluated the effectiveness of the Fund's disclosure controls and procedures as of a date (the "Evaluation Date") within 45 days prior to the filing date of this quarterly report; and
3. presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;



1. The Fund's other certifying officer and I have disclosed, based on our most recent evaluation, to the Fund's auditors and the audit committee of the Fund's board of directors (or persons performing the equivalent function):



1. all significant deficiencies in the design or operation of internal controls which could adversely affect the Fund's ability to record, process, summarize and report financial data and have identified for the Fund's auditors any material weaknesses in internal controls; and
2. any fraud, whether or not material, that involves management or other employees who have a significant role in the Fund's internal controls; and



1. The Fund's other certifying officer and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the Evaluation Date, including any corrective actions with regard to significant deficiencies and material weaknesses.



|Date:February20, 2004 | _/s/ Marc N. Teal                    
|--------------------- | -------------------------------------
|                      | Marc N. Teal, Chief
Financial Officer
78 P.3d 370

INTERMEDIATE COURT OF APPEALS OF HAWAI'I

October 10, 2003

24343

#### State v. Labrador

Affirmed
```

[Federal Register Volume 78, Number 141 (Tuesday, July 23, 2013)]
[Notices]
[Page 44119]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-17701]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9837-3; CERCLA-04-2013-3760]

Circle Environmental 1 Superfund Site; Dawson, Terrell 
County, Georgia; Notice of Settlement

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of settlement.

-----------------------------------------------------------------------

SUMMARY: Under 122(h) of the Comprehensive Environmental Response, 
Compensation and Liability Act (CERCLA), the United States 
Environmental Protection Agency has entered into a settlement with 
Walter G. Mercer, Jr. concerning the Circle Environmental 1 
Superfund Site located in Dawson, Terrell County, Georgia. The 
settlement addresses cost incurred by the agency in conducting a fund 
lead Removal.

DATES: The Agency will consider public comments on the settlement until 
August 22, 2013. The Agency will consider all comments received and may 
modify or withdraw its consent to the settlement if comments received 
disclose facts or considerations which indicate that the settlement is 
inappropriate, improper, or inadequate.

ADDRESSES: Copies of the settlement are available from the Agency by 
contacting Ms. Paula V. Painter, Environmental Protection Specialist 
using the contact information provided in this Notice. Comments may 
also be submitted by referencing the Site's name through one of the 
following methods:
     Internet: www.epa.gov/region4/superfund/programs/enforcement/enforcement.html U.S. Mail: U.S. Environmental Protection Agency, Attn: 
Paula V. Painter, 61 Forsyth Street SW., Atlanta, Georgia 30303.
     Email: Painter.Paula@epa.gov

FOR FURTHER INFORMATION CONTACT: Paula V. Painter at (404) 562-8887.

    Dated: May 21, 2013.
Anita L. Davis,
Chief, Superfund Enforcement & Information Management Branch, Superfund 
Division.
[FR Doc. 2013-17701 Filed 7-22-13; 8:45 am]
BILLING CODE 6560-50-P
```
---------------------------------------------------------------- Electronically Filed Supreme Court SCWC-30710 08-MAY-2014 02:15 PM

SCWC-30710 and SCWC-30711 IN THE SUPREME COURT OF THE STATE OF HAWAI ' I In the Matter of Cost Review Billing Dispute Regarding: DARRELL D. LINOGON, Respondent/Claimant-Appellee,
vs. CITY MILL, Respondent/Employer-Appellee, and ARGONAUT INSURANCE COMPANY, Respondent/Insurance Carrier-Appellee,
vs. EMERSON M.F. JOU, M.D., Petitioner/Appellant-Appellant. (ICA NO. 30710; CASE NO. AB 2009-230 (2-00-14173))
In the Matter of Cost Review Billing Dispute Regarding: CLARITA PINSON, Respondent/Claimant-Appellee,
vs. WAIKIKI BEACH MARRIOTT RESORT, Respondent/Employer-Appellee, and MARRIOTT CLAIMS SERVICE ASSOCIATION, Respondent/Insurance Carrier-Appellee,
vs.EMERSON M.F. JOU, M.D., Petitioner/Appellant-Appellant. (ICA NO. 30711; CASE NO. AB 2009-231 (2-01-06278))

CERTIORARI TO THE INTERMEDIATE COURT OF APPEALS ORDER REJECTING APPLICATIONS FOR WRIT OF CERTIORARI (By: Nakayama, Acting C.J., McKenna, Pollack, and Wilson, JJ., and Circuit Judge Kim, in place of Recktenwald, C.J., recused) Petitioner/Appellant-Appellant’s Applications for Writ of Certiorari, filed on March 26, 2014, is hereby rejected. DATED: Honolulu, Hawai ' i, May 8, 2014. Stephen M. Shaw for petitioner /s/ Paula A. Nakayama /s/ Sabrina S. McKenna /s/ Richard W. Pollack /s/ Michael D. Wilson /s/ Glenn J. Kim

2
[Federal Register Volume 88, Number 234 (Thursday, December 7, 2023)]
[Notices]
[Page 85335]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-26822]


-----------------------------------------------------------------------

POSTAL SERVICE


Product Change--Priority Mail and USPS Ground Advantage[supreg] 
Negotiated Service Agreement

AGENCY: Postal Service<SUP>TM</SUP>.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Postal Service gives notice of filing a request with the 
Postal Regulatory Commission to add a domestic shipping services 
contract to the list of Negotiated Service Agreements in the Mail 
Classification Schedule's Competitive Products List.

DATES: Date of required notice: December 7, 2023.

FOR FURTHER INFORMATION CONTACT: Sean Robinson, 202-268-8405.

SUPPLEMENTARY INFORMATION: The United States Postal Service[supreg] 
hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on 
November 29, 2023, it filed with the Postal Regulatory Commission a 
USPS Request to Add Priority Mail & USPS Ground Advantage[supreg] 
Contract 124 to Competitive Product List. Documents are available at 
www.prc.gov, Docket Nos. MC2024-85, CP2024-87.

Sean Robinson,
Attorney, Corporate and Postal Business Law.
[FR Doc. 2023-26822 Filed 12-6-23; 8:45 am]
BILLING CODE 7710-12-P
Breadcrumb

1. Hogar

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Attending Veterinarians

Last Modified: 

Print

The attending veterinarian is essential to the success of regulated facilities. They

promote animal welfare through the provision of adequate veterinary care and by

overseeing the animal care and use program.

Facilities are required to ensure that their attending veterinarian has the authority to

direct the animal care and use program. This means attending veterinarians may

receive occasional calls from our inspectors either during or after an on-site

inspection to follow up on a facility's program of veterinary care. The information

you provide on behalf of your client will help us ensure the animals are receiving

adequate care in accordance with your guidance.

Who can be an attending veterinarian? 

The Attending Veterinarian's Authority 
The Attending Veterinarian's Duties 

Providing Adequate Veterinary Care 

Written Program of Veterinary Care 

Important Conversations 
Attending Veterinarian and USDA Inspections 

Will citations hurt my license? 

Licensing Rule and Veterinary Care for Dogs 

How To Contact USDA 
FOIA and Medical Records 

More Information

The Attending Veterinarian [Tech Note]

El Veterinario a Cargo [Tech Note]

What All Attending Veterinarians Need to Know (YouTube)

What All Attending Veterinarians Need to Know (PDF)

Antimicrobial Resistance: Role of Attending Veterinarians at Animal Facilities

(YouTube)

Antimicrobial Resistance: Role of Attending Veterinarians at Animal Facilities

(PDF) (2.34 MB)
### 2011 CUE MeBr allocation rule Lee, Amanda I. t o : Drusilla Hufford, Jeremy Arling 03/29/2011 03:52 PM Cc: "Mancini, Dominic J." History: This message has been forwarded.


### Drusilla, I just spoke with Katrina Johnson at EPA about the MeBr rule. I don’t expect any comments from USDA. So let me know when you can upload a clean version into ROCIS, after addressing State comments. Thanks, Amanda